DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 51 filers reported holding DYNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,583,386 | -25.0% | 846,360 | -5.9% | 0.00% | 0.0% |
| Q2 2023 | $10,117,035 | +7.3% | 899,292 | +9.9% | 0.00% | – |
| Q1 2023 | $9,424,650 | +41.6% | 818,112 | +42.5% | 0.00% | -100.0% |
| Q4 2022 | $6,654,051 | +615.5% | 574,120 | +683.9% | 0.00% | – |
| Q3 2022 | $930,000 | +86.0% | 73,242 | +0.6% | 0.00% | – |
| Q2 2022 | $500,000 | -28.7% | 72,833 | +0.1% | 0.00% | – |
| Q1 2022 | $701,000 | +242.0% | 72,767 | +323.1% | 0.00% | – |
| Q4 2021 | $205,000 | -93.8% | 17,200 | -91.9% | 0.00% | – |
| Q1 2021 | $3,284,000 | +33.0% | 211,483 | +79.8% | 0.00% | – |
| Q4 2020 | $2,470,000 | +4.0% | 117,600 | 0.0% | 0.00% | – |
| Q3 2020 | $2,374,000 | – | 117,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |